Lecanemab and APOE Genotyping in Clinical Practice —Navigating Uncharted Terrain

This Viewpoint discusses the findings of the Clarity AD trial, which studied lecanemab for patients with early-stage Alzheimer disease.

Source: JAMA Neurology - March 13, 2023 Category: Neurology Source Type: research